Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research
Background: Conflicts of interest arising from pharmaceutical industry sponsorship of clinical research have the potential to bias research outcomes and ultimately prejudice patient care. It is unknown how Australian Human Research Ethics Committees (HREC) assess and manage such conflicts of interest. We aimed to gain an understanding of how HREC approach the problem of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
No Supplementary Data
No Article Media
Document Type: Research Article
Affiliations: Centre for Values Ethics and the Law in Medicine, University of Sydney, Sydney, New South Wales, Australia
Publication date: January 1, 2007